Dublin · Seed–Late Stage · 12 people tracked
Also known as SEROBA LIFE SCIENCES LIMITED PARTNERSHIP
Investment thesis
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Source: firm website, verified Aug 3, 2026.
Team · 12 people
from the firm's website & public directories
What they invest in
from 25 of 31 portfolio companiesHealthtech ×22Medical Devices ×18Biotech ×16Deep Tech ×6Hardware ×4AI & Machine Learning ×3Digital Health ×3Consumer ×1
HQs:United States×7Ireland×5Germany×2Denmark×1France×1Italy×1
Investments · 31 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 12019 · 12014 · 15 dated
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsJohnson & Johnson Innovation – JJDC
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)Pietro Faccioli(Co-founder)Giovanni Spagnolli(Co-founder, CTO)Maria Letizia Barreca(Co-founder)Graziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalV-Bio VenturesVertis SGRVI PartnersClaris Ventures
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCAgent Capital+2 more
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesThuja CapitalBGV
Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.
FemTechHealthtechMedical Devices
Co-investorsAndera Partners
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioMedPartnersForbionJeito CapitalBioGeneration VenturesPictet Group
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Kurma PartnersV-Bio VenturesBpifranceInvusNovo Holdings+1 more
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsHadean VenturesBioGeneration VenturesCambridge Innovation Capital
Developed next-generation protein drugs for inflammatory diseases and cancer; acquired by J&J in 2014.
Co-investorsAndera PartnersMC Healthcare Ventures
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsAct Venture CapitalACT Venture CapitalClaret Capital PartnersMolten Ventures
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)Anthony I Nunez(Executive Officer, Director)Anthony A. Nunez(Executive Officer, Director)Anthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)
Co-investorsBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSV Health Investors
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesVenture OntarioYsios CapitalAdams Street Partners+2 more
BiotechSunnyvale, US
Richard Ellson(Executive Officer, Director)Tammy Cameron(Executive Officer)Mark Fischer-Colbrie(Executive Officer, Director)
BoardJoseph Smith(Director)Sandra Panem(Director)Joe Keegan(Director)
Co-investorsAndera PartnersKurma PartnersVI PartnersYsios Capital
Azafaros is a biotechnology company developing disease-modifying therapeutics for lysosomal storage disorders (LSDs), with a focus on addressing neurological symptoms.
BiotechMedical Devices
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSV Health Investors
HealthtechSunnyvale, US
James Joye(Executive Officer, Director)Richard Lotti(Executive Officer, Director)
BoardRichard Ferrari(Executive Officer, Director)David Neustaedter(Director)Kenneth Hayes(Director)Daniel O'Mahony(Director)in
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSunstone CapitalYsios Capital
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
Co-investorsEpidarex Capital
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.
BiotechHealthtechMedical DevicesDublin, IE
Sharon Cunningham(CEO & Co-Founder)Orlaith Ryan(CTO & Co-Founder)
Co-investorsKurma PartnersEnterprise Ireland
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsFast Track InitiativeM VenturesPfizer Venture InvestmentsTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.Cambridge Innovation Capital
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)Josh Mandel-Brehm(Co-Founder)
Co-investorsDroia VenturesKurma PartnersPureos BioventuresEQT Life SciencesEurazeoIdinvest Partners
Exits · 2
IPOs and acquisitions across the tracked portfolioCovagen AGacq. by Johnson & JohnsonPrexton Therapeuticsacq. by Lundbeck
Portfolio news
latest coverage across their companiesAlveus Therapeutics · fiercebiotech.com · Aug 12, 2026
Coave Therapeutics · biopharminternational.com · May 26, 2026
Deciphex · founderstoday.news · Oct 3, 2025
Frequently asked questions
- How many investments has Seroba Life Sciences made?
- Seroba Life Sciences has 31 tracked investments, 2 of which have exited via acquisition or IPO, including 2 dated in the last 24 months.
- What stage does Seroba Life Sciences invest at?
- Seroba Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Seroba Life Sciences's typical check size?
- Seroba Life Sciences typically writes checks of $540K – $7.6M.
- What sectors does Seroba Life Sciences focus on?
- Seroba Life Sciences focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Seroba Life Sciences located?
- Seroba Life Sciences is headquartered in Dublin, IE.
- Who does Seroba Life Sciences co-invest with?
- Seroba Life Sciences most often shares deals with Andera Partners, Kurma Partners, Ysios Capital, among 46 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBruno MONTANARI, Partner, SEROBA LIFE SCIENCES
IPEM · Bruno Montanari
Co-investors · 12
Molten Ventures is a European venture capital firm that backs technology founders from Series A onward, providing capital along with expertise and networks to help companies scale globally.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Claris Ventures is an early-stage investor that makes equity investments in biopharma companies with strong scientific evidence and a clear vision.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.
Atlantic Bridge is a growth equity firm investing in deep technology companies across Europe, the UK and the US, using a cross-border value-add strategy and a global platform to help portfolio companies scale internationally.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Karista is a French venture capital firm that invests in tech and early-stage companies, frequently leading funding rounds and supporting founders through strategic guidance and board involvement.
Borski Fund is a venture capital fund that invests in gender-diverse, female-(co)-led companies in the Netherlands and UK, aiming to improve access to financial and social capital for founders.
Firms observed investing alongside Seroba Life Sciences, from public investor directories. Shared companies are the overlap with Seroba Life Sciences's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.